	Targeting HIF-2Î± in renal cell carcinoma: Expanding upon belzutifan. Cancer Rodriguez M, Qin Q, Tambar UK, Brugarolas J. PMID: 41632099 [PubMed - indexed for MEDLINE]
	A comparative evaluation of large language models for simplifying prostate cancer pathology reports: ChatGPT and Gemini. Int J Surg Zeng H, Yuan Y, Wu X, Ye Z, Yuan H, Luo S, Zhang K, Wang L, Liu H, Yang H. PMID: 41632012 [PubMed - as supplied by publisher]
	The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-Analysis. Clin Nucl Med Mourato FA, Schmitt LG, Mariussi M, Torri G, Altmayer S, Metser U, Veit-Haibach P, Brandão S, Purysko AS, Woo S, Dias AB. PMID: 41631935 [PubMed - as supplied by publisher]
	A Pilot Trial of Two-Fraction Stereotactic Body Radiation Therapy for Localized Prostate Cancer. Cureus Shen X, Chen M, Cao Y, Schroeder A, Miller L, Shiao JC. PMID: 41631234 [PubMed]
	Evaluation of Magnetic Resonance Imaging-Derived SyntheticÂ Computed Tomography in Prostate Cancer Carbon Ion Radiotherapy: Impact of Fixation Shell. Int J Part Ther Ishizawa M, Haga K, Sato H, Miyasaka Y, Souda H, Chai H, Iwai T. PMID: 41631158 [PubMed]
	Persistent Hypercalcemia: Diagnostic Complexity With Multiglandular Hyperparathyroidism, Renal Cell Carcinoma, and Hereditary Tumor Features. Cureus Yuska T, Clark M, Goldman Gollan Y. PMID: 41631080 [PubMed]
	Psoas metastasis mimicking abscess in untreated muscle-invasive bladder cancer: A diagnostic pitfall. Radiol Case Rep Youssef M, Nasseredine B, Amine Z, Amine S, Tariq K, Abdellatif K, Khalid E. PMID: 41631042 [PubMed]
	Diagnostic Value of Transabdominal Ultrasound-based Versus Magnetic Resonance Imaging-based Prostate-specific Antigen Density for Clinically Significant Prostate Cancer. Eur Urol Open Sci Xu Z, Song H, Huang H, Fu M, Tang Y, Zhang P, Zhang G, Li J. PMID: 41631039 [PubMed]
	Re: Amar U. Kishan, Luca F. Valle, Holly Wilhalme, et al. (177)Lu-Prostate-specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025;43:3812-21. Eur Urol Open Sci Achard V, Zilli T, Tombal B. PMID: 41631038 [PubMed]
	Editorial Comment on: "Enhanced Artificial Intelligence in Bladder Cancer Management: A Comparative Analysis and Optimization Study of Multiple Large Language Models" by Li et al. J Endourol Meng X, Su CY, Yang Z. PMID: 41630170 [PubMed - as supplied by publisher]
	Fecal incontinence after prostate cancer irradiation: a systematic literature review. Prostate Cancer Prostatic Dis Benizri D, Duchalais-Dassonneville E, Gautier M, Hannoun-Levi JM. PMID: 41629638 [PubMed - as supplied by publisher]
	CAIX-targeted PET/CT in the evaluation of clear cell renal cell carcinoma: a head-to-head comparison with [(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging Guo W, Cheng L, Zhou X, Zhao Y, Chen H, Zhang Y, Qin Y, Liu W, Hu G, Yang X, You H, Wei W, Hou D, Jiang H, Wang K. PMID: 41629415 [PubMed - as supplied by publisher]
	Protocol for the PROSECCA study: a new approach for predicting radiotherapy outcome using artificial intelligence and electronic population-based healthcare data. BMJ Open Nailon WH, Noble DJ, Harrison E, Yang Z, Elliot S, MacNair A, Beckett G, Hallam A, Sheikh A, Mills N, Halliday R, Morrison D, Chalmers A, Cameron D, Gourley C, Hall P, Lilley C, Carruthers LJ, Trainer M, Burns D, Dee F, Andiappa S, Lonsdale A, Couper M, Farnan K, McLellan J, Miller A, Ogg J, Moses J, Colligan S, MacDonald G, McPhail N, Niblock P, MacLeod N, Davies ME, Laurenson DI, Hopgood JR, Boyle D, Paterson C, Grose D, Phillips I, Harrow S, Berger T, Shelley LEA, Sanders I, Henderson S, Duffton A, Mitchell J, Rutherford A, McLaren DB. PMID: 41628931 [PubMed - indexed for MEDLINE]
	Clinical Outcomes Following Transurethral Laser Ablation with Topical Versus General or Spinal Anesthesia for Non-Muscle-Invasive Bladder Cancer: A Japanese Single-Center Pilot Study. Photodiagnosis Photodyn Ther Yamamoto S, Fukata S, Shimasaki S, Kurano Y, Yamashita E, Atagi K, Shigehisa R, Osakabe H, Nao T, Shimamoto T, Fukuhara H, Shimizu N, Ashida S, Inoue K. PMID: 41628787 [PubMed - as supplied by publisher]
	A nomogram including body composition parameters for predicting recurrence of pT1 clear cell renal cell carcinoma: a multicenter retrospective study. Insights Imaging Chen H, Cai L, Zhuang J, Tao Y, Tan Z, Yu H, Chen C, Wu Q, Cao Q, Liang B, Li P, Yang X, Lu Q. PMID: 41627715 [PubMed]
	Radiomics to Differentiate Renal Oncocytoma from Clear Cell Renal Cell Carcinoma on Contrast-Enhanced CT: A Preliminary Study. J Imaging Inform Med Liu F, Jia L, Zhou X, Yu L. PMID: 41627644 [PubMed - as supplied by publisher]
	Sexual distress in patients after radical cystectomy for bladder cancer: a qualitative study. Support Care Cancer Zhang M, Zhou Y. PMID: 41627516 [PubMed - indexed for MEDLINE]
	Improving outcomes of patients with advanced prostate cancer through a better understanding of clinical factors contributing to financial toxicity: a qualitative study. Support Care Cancer Olunuga E, Kurnot J, Zhu S, George DJ, Docherty SL, Kaye DR. PMID: 41627480 [PubMed - indexed for MEDLINE]
	Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years. JAMA Netw Open Lindholz M, Bülow R, Schoots IG, Kölln M, Nolte S, Baumgärtner GL, Chenot JF, Schmidt CO, Burchardt M, Nauck M, Völzke H, Wielpütz MO, Penzkofer T, Hosten N, Hamm CA. PMID: 41627816 [PubMed - indexed for MEDLINE]
	Developing an approach for assigning GRADE levels in a systematic overview of reviews of diagnostic test accuracy using general principles identified from current GRADE guidelines: A case study. Res Synth Methods Dullea A, O'Sullivan L, O'Brien KK, Harrington P, Carrigan M, Ahern S, McGarry M, Cardwell K, O'Neill M, Walsh KA, Clyne B, Smith SM, Ryan M. PMID: 41626885 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 175699

Page 1 of 8785



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy